---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-001348"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:12:26.645674+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics raises ~$4.0M in registered direct offering of 2.97M shares at $1.55/share

## Summary
- Sold 2,967,742 common shares at $1.55 each; net proceeds ~$4.0M after fees and expenses.
- Offering closed on January 16, 2024; proceeds for general corporate purposes (R&D, SG&A, working capital).
- Exercise price of May 2019 warrants (193,060 outstanding) reduced from $3.52 to $1.55 per share due to anti-dilution.
- A.G.P./Alliance Global Partners acted as exclusive placement agent; fee of 7% of gross proceeds plus expense reimbursements.

## SEC filing metadata
- accession: 0001437749-24-001348
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000143774924001348/0001437749-24-001348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000143774924001348/ekso20240111_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-001348
- JSON: https://secwatch.observer/filing/0001437749-24-001348.json
- Plain text: https://secwatch.observer/filing/0001437749-24-001348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.